Updated Date:
23 Sep 2026
Product Detail:
ZOLADEX Goserelin 3.6mg (as Acetate) Implant Syringe
Shortage Status:
Resolved
AUST R:
24368
Availability:
Available
Active Ingredient:
goserelin
Reason:
Commercial Changes / Commercial viability
Dosage Form:
Implant
Supply Impact Dates
From 22 Sep 2026
To 22 Sep 2026
Management Action:
The sponsor has advised that this product will continue to be supplied. Further details are available through the following link: www.astrazeneca.com.au/news/media-releases/2026/ASTRAZENECA-TO-EXTEND-PBS-ACCESS-TO-ZOLADEX-goserelin-MONTHLY-3_6mg-IMPLANT.html